Rydland HT, Friedman J, Stringhini S, Hyperlink BG, Eikemo TA. The radically unequal distribution of Covid-19 vaccinations: a predictable but avoidable symptom of the elemental causes of inequality. Humanit Soc Sci Commun. 2022;9:1–16.
Jalali N, Brustad HK, Frigessi A, MacDonald EA, Meijerink H, Feruglio SL, et al. Elevated family transmission and immune escape of the SARS-CoV-2 Omicron in comparison with Delta variants. Nat Commun. 2022;13:5706.
Jamison DA Jr, Anand Narayanan S, Trovão NS, Guarnieri JW, Topper MJ, Moraes-Vieira PM, et al. A complete SARS-CoV-2 and COVID-19 overview, Half 1: Intracellular overdrive for SARS-CoV-2 an infection. Eur J Hum Genet. 2022;30:889–98.
Prasad Okay, Khatoon F, Rashid S, Ali N, AlAsmari AF, Ahmed MZ, et al. Focusing on hub genes and pathways of innate immune response in COVID-19: a community biology perspective. Int J Biol Macromol. 2020;163:1–8.
Minakshi R, Padhan Okay, Rani M, Khan N, Ahmad F, Jameel S. The SARS Coronavirus 3a protein causes endoplasmic reticulum stress and induces ligand-independent downregulation of the sort 1 interferon receptor. PLoS ONE. 2009;4:e8342.
Guarnieri JW, Dybas JM, Fazelinia H, Kim MS, Frere J, Zhang Y, et al. Core mitochondrial genes are down-regulated throughout SARS-CoV-2 an infection of rodent and human hosts. Sci Transl Med. 2023;15:eabq1533.
Shen B, Yi X, Solar Y, Bi X, Du J, Zhang C, et al. Proteomic and metabolomic characterization of COVID-19 affected person sera. Cell. 2020;182:59–72.
Cheng ZJ, Yang X, Wang H. Hyperhomocysteinemia and endothelial dysfunction. Curr Hypertens Rev. 2009;5:158–65.
Barberis E, Timo S, Amede E, Vanella VV, Puricelli C, Cappellano G, et al. Massive-scale plasma evaluation revealed new mechanisms and molecules related to the host response to SARS-CoV-2. Int J Mol Sci. 2020;21:8623.
Schwarz B, Sharma L, Roberts L, Peng X, Bermejo S, Leighton I, et al. Extreme SARS-CoV-2 an infection in people is outlined by a shift within the serum lipidome leading to dysregulation of eicosanoid immune mediators. J Immunol. 2021;206:329.
Thomas T, Stefanoni D, Reisz JA, Nemkov T, Bertolone L, Francis RO, et al. COVID-19 an infection alters kynurenine and fatty acid metabolism, correlating with IL-6 ranges and renal standing. JCI perception. 2020;5:e140327.
Tanner JE, Alfieri C. The fatty acid lipid metabolism nexus in COVID-19. Viruses. 2021;13:90.
Garvin MR, Alvarez C, Miller JI, Prates ET, Walker AM, Amos BK, et al. A mechanistic mannequin and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm. elife. 2020;9:e59177.
Clarke SA, Abbara A, Dhillo WS. Affect of COVID-19 on the endocrine system: a mini-review. Endocrinology. 2022;163:bqab203.
Lazartigues E, Qadir MM, Mauvais-Jarvis F. Endocrine significance of SARS-CoV-2’s reliance on ACE2. Endocrinology. 2020;161:bqaa108.
Kitsou Okay, Kotanidou A, Paraskevis D, Karamitros T, Katzourakis A, Tedder R, et al. Upregulation of human endogenous retroviruses in bronchoalveolar lavage fluid of COVID-19 sufferers. Microbiol Spectr. 2021;9:e01260–21.
Alfaro E, Díaz-García E, García-Tovar S, Zamarrón E, Mangas A, Galera R, et al. Impaired kallikrein-kinin system in COVID-19 sufferers’ severity. Entrance Immunol. 2022;13:909342.
Sur S, Steele R, Isbell TS, Ray R, Ray RB. Circulatory exosomes from COVID-19 sufferers set off NLRP3 inflammasome in endothelial cells. Mbio. 2022;13:e00951–22.
Pesce E, Manfrini N, Cordiglieri C, Santi S, Bandera A, Gobbini A, et al. Exosomes recovered from the plasma of COVID-19 sufferers expose SARS-CoV-2 spike-derived fragments and contribute to the adaptive immune response. Entrance Immunol. 2022;12:785941.
Ching KL, de Vries M, Gago J, Dancel-Manning Okay, Sall J, Rice WJ, et al. ACE2-containing defensosomes function decoys to inhibit SARS-CoV-2 an infection. PLoS Biol. 2022;20:e3001754.
Peluso MJ, Deeks SG, Mustapic M, Kapogiannis D, Henrich TJ, Lu S, et al. SARS‐CoV‐2 and mitochondrial proteins in neural‐derived exosomes of COVID‐19. Ann Neurol. 2022;91:772–81.
Leitão AL, Enguita FJ. A structural view of miRNA biogenesis and performance. Noncoding RNA. 2022;8:10.
Farr RJ, Rootes CL, Rowntree LC, Nguyen TH, Hensen L, Kedzierski L, et al. Altered microRNA expression in COVID-19 sufferers permits identification of SARS-CoV-2 an infection. PLoS Pathog. 2021;17:e1009759.
McDonald JT, Enguita FJ, Taylor D, Griffin RJ, Priebe W, Emmett MR, et al. Function of miR-2392 in driving SARS-CoV-2 an infection. Cell Rep. 2021;37:109839.
Panda M, Kalita E, Singh S, Kumar Okay, Rao A, Prajapati VK. MiRNA-SARS-CoV-2 dialogue and potential anti-COVID-19 therapies. Life Sci. 2022:120761.
Shaath H, Vishnubalaji R, Elkord E, Alajez NM. Single-cell transcriptome evaluation highlights a job for neutrophils and inflammatory macrophages within the pathogenesis of extreme COVID-19. Cells. 2020;9:2374.
Mukherjee S, Banerjee B, Karasik D, Frenkel-Morgenstern M. mRNA-lncRNA Co-expression community evaluation reveals the function of lncRNAs in immune dysfunction throughout extreme SARS-CoV-2 an infection. Viruses. 2021;13:402.
Devadoss D, Acharya A, Manevski M, Houserova D, Cioffi MD, Pandey Okay, et al. Immunomodulatory LncRNA on antisense strand of ICAM-1 augments SARS-CoV-2 infection-associated airway mucoinflammatory phenotype. Iscience. 2022;25:104685.
Enguita FJ, Leitão AL, McDonald JT, Zaksas V, Das S, Galeano D, et al. The interaction between lncRNAs, RNA-binding proteins and viral genome throughout SARS-CoV-2 an infection reveals robust connections with regulatory occasions concerned in RNA metabolism and immune response. Theranostics. 2022;12:3946.
Sullivan KD, Galbraith MD, Kinning KT, Bartsch KW, Levinsky NC, Araya P, et al. The COVIDome explorer researcher portal. Cell Rep. 2021;36:109527.
Yang M, Qi M, Xu L, Huang P, Wang X, Solar J, et al. Differential host circRNA expression profiles in human lung epithelial cells contaminated with SARS-CoV-2. Infect, Genet Evol. 2021;93:104923.
Wu Y, Zhao T, Deng R, Xia X, Li B, Wang X. A examine of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood. Sci Rep. 2021;11:7991.
Farshidfar F, Koleini N, Ardehali H. Cardiovascular problems of COVID-19. JCI perception. 2021;6:e148980.
Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. COVID-19 and heart problems. Circulation. 2020;141:1648–55.
Park J, Foox J, Hether T, Danko DC, Warren S, Kim Y, et al. System-wide transcriptome harm and tissue id loss in COVID-19 sufferers. Cell Rep. Med. 2022;3:100522.
Lindner D, Fitzek A, Bräuninger H, Aleshcheva G, Edler C, Meissner Okay, et al. Affiliation of cardiac an infection with SARS-CoV-2 in confirmed COVID-19 post-mortem instances. JAMA Cardiol. 2020;5:1281–5.
Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell an infection and endotheliitis in COVID-19. Lancet. 2020;395:1417–8.
Monteil V, Kwon H, Prado P, Hagelkrüys A, Wimmer RA, Stahl M, et al. Inhibition of SARS-CoV-2 infections in engineered human tissues utilizing clinical-grade soluble human ACE2. Cell. 2020;181:905–13.
Chang R, Mamun A, Dominic A, Le NT. SARS-CoV-2 mediated endothelial dysfunction: the potential function of persistent oxidative stress. Entrance Physiol. 2021;11:605908.
Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: the cornerstone of organ dysfunction in extreme SARS-CoV-2 an infection. Crit Care. 2020;24:1–8.
Tersalvi G, Vicenzi M, Calabretta D, Biasco L, Pedrazzini G, Winterton D. Elevated troponin in sufferers with coronavirus illness 2019: potential mechanisms. J Card Fail. 2020;26:470–5.
Arcanjo A, Logullo J, Menezes CC, de Souza Carvalho Giangiarulo TC, Dos Reis MC, de Castro GM, et al. The rising function of neutrophil extracellular traps in extreme acute respiratory syndrome coronavirus 2 (COVID-19). Sci Rep. 2020;10:19630.
Karki R, Lee S, Mall R, Pandian N, Wang Y, Sharma BR, et al. ZBP1-dependent inflammatory cell demise, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy throughout coronavirus an infection. Sci Immunol. 2022;7:eabo6294.
Rendeiro AF, Ravichandran H, Bram Y, Chandar V, Kim J, Meydan C, et al. The spatial panorama of lung pathology throughout COVID-19 development. Nature. 2021;593:564–9.
Cheon IS, Li C, Son YM, Goplen NP, Wu Y, Cassmann T, et al. Immune signatures underlying post-acute COVID-19 lung sequelae. Sci Immunol. 2021;6:eabk1741.
Gonçalves JJ, da Mata CP, Lourenço AA, Ribeiro ÁL, Ferreira GM, Fraga-Silva TF, et al. Timeline kinetics of systemic and airway immune mediator storm for complete evaluation of illness consequence in critically in poor health COVID-19 sufferers. Entrance Immunol. 2022;13:903903.
Truffaut L, Demey L, Bruyneel AV, Roman A, Alard S, De Vos N, et al. Publish-discharge important COVID-19 lung operate associated to severity of radiologic lung involvement at admission. Respir Res. 2021;22:1–6.
Melms JC, Biermann J, Huang H, Wang Y, Nair A, Tagore S, et al. A molecular single-cell lung atlas of deadly COVID-19. Nature. 2021;595:114–9.
Singh Y, Trautwein C, Fendel R, Krickeberg N, Berezhnoy G, Bissinger R, et al. SARS-CoV-2 an infection paralyzes cytotoxic and metabolic capabilities of the immune cells. Heliyon. 2021;7:e07147.
Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184:861–80.
Onofrio L, Caraglia M, Facchini G, Margherita V, Placido SD, Buonerba C. Toll-like receptors and COVID-19: a two-faced story with an thrilling ending. Future Sci OA. 2020;6:FSO605.
Patra R, Das NC, Mukherjee S. Focusing on human TLRs to fight COVID‐19: an answer? J Med Virol. 2021;93:615.
Merad M, Martin JC. Pathological irritation in sufferers with COVID-19: a key function for monocytes and macrophages. Nat Rev Immunol. 2020;20:355–62.
Mancini I, Baronciani L, Artoni A, Colpani P, Biganzoli M, Cozzi G, et al. The ADAMTS13‐von Willebrand issue axis in COVID‐19 sufferers. J Thromb Haemost. 2021;19:513–21.
Hojyo S, Uchida M, Tanaka Okay, Hasebe R, Tanaka Y, Murakami M, et al. How COVID-19 induces cytokine storm with excessive mortality. Inflamm Regen. 2020;40:1–7.
Tan C, Li S, Liang Y, Chen M, Liu J. SARS-CoV-2 viremia might predict speedy deterioration of COVID-19 sufferers. Braz J Infect Dis. 2021;24:565–9.
Bryce C, Grimes Z, Pujadas E, Ahuja S, Beasley MB, Albrecht R, et al. Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 post-mortem expertise. Mod Pathol. 2021;34:1456–67.
Hadjadj J, Yatim N, Barnabei L, Corneau A, Boussier J, Smith N, et al. Impaired sort I interferon exercise and inflammatory responses in extreme COVID-19 sufferers. Science. 2020;369:718–24.
Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, et al. Profiling serum cytokines in COVID-19 sufferers reveals IL-6 and IL-10 are illness severity predictors. Emerg Microbes Infect. 2020;9:1123–30.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Medical options of sufferers contaminated with 2019 novel coronavirus in Wuhan, China. lancet. 2020;395:497–506.
Liu Okay, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Medical traits of novel coronavirus instances in tertiary hospitals in Hubei Province. Chin Med J. 2020;133:1025–31.
Azarkish M, Laleh Far V, Eslami M, Mollazadeh R. Transient full coronary heart block in a affected person with important COVID-19. Eur Coronary heart J. 2020;41:2131.
Chen G, Wu DI, Guo W, Cao Y, Huang D, Wang H, et al. Medical and immunological options of extreme and reasonable coronavirus illness 2019. J Clin Investig. 2020;130:2620–9.
Pons S, Arnaud M, Loiselle M, Arrii E, Azoulay E, Zafrani L. Immune penalties of endothelial cells’ activation and dysfunction throughout sepsis. Crit Care Clin. 2020;36:401–13.
Yao XH, Luo T, Shi Y, He ZC, Tang R, Zhang PP, et al. A cohort post-mortem examine defines COVID-19 systemic pathogenesis. Cell Res. 2021;31:836–46.
Nobari NN, Montazer F, Seirafianpour F, Nikkhah F, Aryanian Z, Goodarzi A. Histopathologic modifications and mobile occasions of organs techniques in COVID-19. J Cell Mol Anesth. 2021;6:81–8.
Shah MD, Sumeh AS, Sheraz M, Kavitha MS, Maran BA, Rodrigues KF. A mini-review on the influence of COVID 19 on important organs. Biomed Pharmacother. 2021;143:112158.
Stein SR, Ramelli SC, Grazioli A, Chung JY, Singh M, Yinda CK, et al. SARS-CoV-2 an infection and persistence within the human physique and mind at post-mortem. Nature. 2022;612:758–63.
Stafstrom CE. Neurological results of COVID‐19 in infants and kids. Dev Med Little one Neurol. 2022;64:818–29.
Crunfli F, Carregari VC, Veras FP, Silva LS, Nogueira MH, Antunes AS, et al. Morphological, mobile, and molecular foundation of mind an infection in COVID-19 sufferers. Proc Natl Acad Sci USA. 2022;119:e2200960119.
Zhang L, Zhou L, Bao L, Liu J, Zhu H, Lv Q, et al. SARS-CoV-2 crosses the blood–mind barrier accompanied with basement membrane disruption with out tight junctions alteration. Sig Transduct Goal Ther. 2021;6:337.
Livanos AE, Jha D, Cossarini F, Gonzalez-Reiche AS, Tokuyama M, Aydillo T, et al. Intestinal host response to SARS-CoV-2 an infection and COVID-19 outcomes in sufferers with gastrointestinal signs. Gastroenterology. 2021;160:2435–50.
Nalbandian A, Sehgal Okay, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Publish-acute COVID-19 syndrome. Nat Med. 2021;27:601–15.
Criminal H, Raza S, Nowell J, Younger M, Edison P Lengthy covid—mechanisms, danger components, and administration. BMJ. 2021;374:n1648.
de Melo GD, Lazarini F, Levallois S, Hautefort C, Michel V, Larrous F, et al. COVID-19–associated anosmia is related to viral persistence and irritation in human olfactory epithelium and mind an infection in hamsters. Sci Transl Med. 2021;13:eabf8396.
Pretorius E, Venter C, Laubscher GJ, Kotze MJ, Oladejo SO, Watson LR, et al. Prevalence of signs, comorbidities, fibrin amyloid microclots and platelet pathology in people with Lengthy COVID/Publish-Acute Sequelae of COVID-19 (PASC). Cardiovasc Diabetol. 2022;21:148.
Castanares-Zapatero D, Chalon P, Kohn L, Dauvrin M, Detollenaere J, Maertens de Noordhout C, et al. Pathophysiology and mechanism of lengthy COVID: a complete overview. Ann Med. 2022;54:1473–87.
Vaira LA, Hopkins C, Sandison A, Manca A, Machouchas N, Turilli D, et al. Olfactory epithelium histopathological findings in long-term coronavirus illness 2019 associated anosmia. J Laryngol Otol. 2020;134:1123–7.
Guedj E, Campion JY, Dudouet P, Kaphan E, Bregeon F, Tissot-Dupont H, et al. 18F-FDG mind PET hypometabolism in sufferers with lengthy COVID. Eur J Nucl Med Mol Imaging. 2021;48:2823–33.
Wooden E, Corridor KH, Tate W. Function of mitochondria, oxidative stress and the response to antioxidants in myalgic encephalomyelitis/persistent fatigue syndrome: a potential strategy to SARS-CoV-2 ‘long-haulers’? Continual Dis Transl Med. 2021;7:14–26.
Korompoki E, Gavriatopoulou M, Hicklen RS, Ntanasis-Stathopoulos I, Kastritis E, Fotiou D, et al. Epidemiology and organ particular sequelae of post-acute COVID19: a story overview. J Infect. 2021;83:1–6.
Phetsouphanh C, Darley DR, Wilson DB, Howe A, Munier CM, Patel SK, et al. Immunological dysfunction persists for 8 months following preliminary mild-to-moderate SARS-CoV-2 an infection. Nat Immunol. 2022;23:210–6.
Discover more from PressNewsAgency
Subscribe to get the latest posts sent to your email.